vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and NICOLET BANKSHARES INC (NIC). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $104.0M, roughly 2.0× NICOLET BANKSHARES INC). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 38.8%, a 18.6% gap on every dollar of revenue. NICOLET BANKSHARES INC produced more free cash flow last quarter ($149.4M vs $142.2M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Nicolet Bankshares, Inc. is a U.S. regional bank holding company based in Green Bay, Wisconsin. They are the parent company of Nicolet National Bank, the second largest Wisconsin-based bank.
IDYA vs NIC — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $104.0M |
| Net Profit | $119.2M | $40.3M |
| Gross Margin | — | — |
| Operating Margin | 52.2% | 48.3% |
| Net Margin | 57.4% | 38.8% |
| Revenue YoY | — | 12.5% |
| Net Profit YoY | 330.1% | 16.9% |
| EPS (diluted) | $1.33 | $2.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $104.0M | ||
| Q3 25 | $207.8M | $102.9M | ||
| Q2 25 | — | $95.7M | ||
| Q1 25 | — | $89.4M | ||
| Q4 24 | — | $92.4M | ||
| Q3 24 | $0 | $90.7M | ||
| Q2 24 | $0 | $85.0M | ||
| Q1 24 | $0 | $82.2M |
| Q4 25 | — | $40.3M | ||
| Q3 25 | $119.2M | $41.7M | ||
| Q2 25 | — | $36.0M | ||
| Q1 25 | — | $32.6M | ||
| Q4 24 | — | $34.5M | ||
| Q3 24 | $-51.8M | $32.5M | ||
| Q2 24 | $-52.8M | $29.3M | ||
| Q1 24 | $-39.6M | $27.8M |
| Q4 25 | — | 48.3% | ||
| Q3 25 | 52.2% | 50.4% | ||
| Q2 25 | — | 46.8% | ||
| Q1 25 | — | 44.9% | ||
| Q4 24 | — | 46.8% | ||
| Q3 24 | — | 45.0% | ||
| Q2 24 | — | 43.3% | ||
| Q1 24 | — | 41.8% |
| Q4 25 | — | 38.8% | ||
| Q3 25 | 57.4% | 40.6% | ||
| Q2 25 | — | 37.6% | ||
| Q1 25 | — | 36.4% | ||
| Q4 24 | — | 37.3% | ||
| Q3 24 | — | 35.8% | ||
| Q2 24 | — | 34.5% | ||
| Q1 24 | — | 33.8% |
| Q4 25 | — | $2.63 | ||
| Q3 25 | $1.33 | $2.73 | ||
| Q2 25 | — | $2.34 | ||
| Q1 25 | — | $2.08 | ||
| Q4 24 | — | $2.21 | ||
| Q3 24 | $-0.60 | $2.10 | ||
| Q2 24 | $-0.68 | $1.92 | ||
| Q1 24 | $-0.53 | $1.82 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | — |
| Total DebtLower is stronger | — | $134.9M |
| Stockholders' EquityBook value | $1.1B | $1.3B |
| Total Assets | $1.2B | $9.2B |
| Debt / EquityLower = less leverage | — | 0.11× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $786.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $920.0M | — | ||
| Q2 24 | $701.7M | — | ||
| Q1 24 | $698.8M | — |
| Q4 25 | — | $134.9M | ||
| Q3 25 | — | $134.6M | ||
| Q2 25 | — | $134.3M | ||
| Q1 25 | — | $156.6M | ||
| Q4 24 | — | $161.4M | ||
| Q3 24 | — | $161.2M | ||
| Q2 24 | — | $162.4M | ||
| Q1 24 | — | $162.3M |
| Q4 25 | — | $1.3B | ||
| Q3 25 | $1.1B | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | $1.2B | $1.1B | ||
| Q2 24 | $931.7M | $1.1B | ||
| Q1 24 | $935.3M | $1.1B |
| Q4 25 | — | $9.2B | ||
| Q3 25 | $1.2B | $9.0B | ||
| Q2 25 | — | $8.9B | ||
| Q1 25 | — | $9.0B | ||
| Q4 24 | — | $8.8B | ||
| Q3 24 | $1.2B | $8.6B | ||
| Q2 24 | $973.7M | $8.6B | ||
| Q1 24 | $961.5M | $8.4B |
| Q4 25 | — | 0.11× | ||
| Q3 25 | — | 0.11× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $153.5M |
| Free Cash FlowOCF − Capex | $142.2M | $149.4M |
| FCF MarginFCF / Revenue | 68.4% | 143.7% |
| Capex IntensityCapex / Revenue | 0.0% | 3.9% |
| Cash ConversionOCF / Net Profit | 1.19× | 3.81× |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $275.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $153.5M | ||
| Q3 25 | $142.2M | $45.9M | ||
| Q2 25 | — | $38.9M | ||
| Q1 25 | — | $41.8M | ||
| Q4 24 | — | $133.7M | ||
| Q3 24 | $-49.2M | $39.6M | ||
| Q2 24 | $-32.9M | $37.3M | ||
| Q1 24 | $-43.8M | $23.4M |
| Q4 25 | — | $149.4M | ||
| Q3 25 | $142.2M | $45.9M | ||
| Q2 25 | — | $38.4M | ||
| Q1 25 | — | $41.3M | ||
| Q4 24 | — | $116.8M | ||
| Q3 24 | $-49.7M | $34.7M | ||
| Q2 24 | $-33.9M | $34.4M | ||
| Q1 24 | $-45.1M | $20.1M |
| Q4 25 | — | 143.7% | ||
| Q3 25 | 68.4% | 44.6% | ||
| Q2 25 | — | 40.1% | ||
| Q1 25 | — | 46.2% | ||
| Q4 24 | — | 126.4% | ||
| Q3 24 | — | 38.3% | ||
| Q2 24 | — | 40.5% | ||
| Q1 24 | — | 24.4% |
| Q4 25 | — | 3.9% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 18.3% | ||
| Q3 24 | — | 5.4% | ||
| Q2 24 | — | 3.5% | ||
| Q1 24 | — | 4.0% |
| Q4 25 | — | 3.81× | ||
| Q3 25 | 1.19× | 1.10× | ||
| Q2 25 | — | 1.08× | ||
| Q1 25 | — | 1.28× | ||
| Q4 24 | — | 3.88× | ||
| Q3 24 | — | 1.22× | ||
| Q2 24 | — | 1.28× | ||
| Q1 24 | — | 0.84× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
